Registry for cardioneuroablation in patients with recurrent vasovagal syncope
Official title: National Registry of Cardioneuroablation in Recurrent Reflex Syncope
Run by University Hospital, Bordeaux · NCT06159764 · Data updated 2026-11-12
This study is collecting information to see how well a new treatment called cardioneuroablation works for people with frequent fainting spells caused by vasovagal syncope.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 14 sites (Bron and 13 other locations) |
| Status | Recruiting |
| Started | November 27, 2024 |
| Main results expected | January 31, 2026 |
| Study ends | January 31, 2026 |
| Registry record updated | June 17, 2025 |
| Trial ID | NCT06159764 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 or older with recurrent vasovagal syncope and documented asystolic episodes who are scheduled for a cardioneuroablation procedure.
✕Probably not a fit
Patients with contraindications to anticoagulation therapy, cardiac CT, or those with intracardiac thrombus will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data on the effectiveness of cardioneuroablation for treating recurrent vasovagal syncope across multiple centers in France. The study aims to evaluate success rates, compare different techniques, and assist institutions in establishing their own cardioneuroablation programs. By utilizing radiofrequency ablation to target cardiac ganglionated plexi, the registry seeks to answer key questions regarding patient selection, optimal targeting of fat pads, and long-term outcomes of the procedure. The multicenter approach allows for a comprehensive analysis at minimal cost.
Why it matters
Potential benefit: If successful, this registry could improve treatment options and outcomes for patients suffering from recurrent vasovagal syncope.
How similar studies have gone: While cardioneuroablation is an emerging technique, this registry approach is relatively novel and aims to fill gaps in existing knowledge.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 or more * Recurrent vasovagal syncope (≥2 episodes during the last year) with an asystolic component (≥3 second pause) recorded during a spontaneous episode. The asystole can be related to sinus arrest or paroxysmal AV block. * Scheduled cardioneuroablation procedure * Estimated residual battery life ≥ 1 year. * Patient affiliated to or beneficiary of national health security scheme. * Patient who have received an information notice and has not objected to the use of their data in the registry. Exclusion Criteria: * Contraindication to anticoagulation therapy: major bleeding, risk of major bleeding, severe hepatic disease * Contraindication to cardiac CT: contrast medium allergies * Intracardiac thrombus * Patient detained by judicial or administrative decision.
Where it's running
-
Hôpital Louis Pradel
Bron, France Recruiting -
CHU Clermont-Ferrand
Clermont-Ferrand, France Recruiting -
Hôpital de la Timone
Marseille, France Recruiting -
Clinique du Millénaire
Montpellier, France Recruiting -
Hôpital Pitié-Salpêtriére
Paris, France Recruiting -
Hôpital européen Georges Pompidou
Paris, France Recruiting
Show 8 more locations
-
Hôpital Haut-Lévèque
Pessac, France Recruiting -
CHR Pontchaillou
Rennes, France Recruiting -
Centre cardiologique du Nord
Saint-Denis, France Recruiting -
Clinique Pasteur
Toulouse, France Recruiting -
CHU de Toulouse
Toulouse, France Recruiting -
CHU Lille
Lille, France Not yet recruiting -
CHU de Montpellier
Montpellier, France Not yet recruiting -
Institut ARNAULT TZANCK
Saint-Laurent-du-Var, France Not yet recruiting
Study contacts
- Principal investigator: Josselin DUCHATEAU — University Hospital, Bordeaux
- Study coordinator: Josselin DUCHATEAU
- Email: josselin.duchateau@chu-bordeaux.fr
- Phone: +33 5 57 65 64 71
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Conduction System Pacing Display Research During LBBAP Implant
Researchers are testing a CSP Display System during left bundle branch area pacing pacemaker implant to see if it accurately shows heart signals compared with a standard ECG.
-
Personalized pacing rate to see if higher lower rate helps heart and brain flow
In hypertensive patients with bradycardia who need a dual-chamber pacemaker, the study tests whether setting a higher, personalized pacing rate improves heart function and brain blood flow compared with the standard 60 bpm.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.